{"id":"3d5c8a2a-7746-46ea-adaf-535bc0ef27ae","kind":"news","code":"3d5c8a2a-7746-46ea-adaf-535bc0ef27ae","name":"Phil Rivers raises RMB 100 million in Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"哲源科技完成1亿人民币A轮融资","eventDate":"2022-06-15T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:38:22.624Z","englishUpdatedAt":"2026-10-15T17:19:59.417Z","reviewedAt":"2026-10-15T17:19:59.417Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"194e86a2847d916a92d0da9a0ad34d3ae7b1282522683af4ca1b00c9bddea053","companyId":"379cea5b-ef8c-4bca-a8e9-dac76fb4710d","foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"fbca5a9d-228a-426d-8ee0-3645207f7491","kind":"institutions","code":"UB-I5944","name":"Boxing Capital","nameBasis":"transliterated","summary":"Boxing Capital, a Chinese equity investment firm focused on equity investments in startup-stage technology companies.","description":"Boxing Capital, a Chinese equity investment firm focused on equity investments in startup-stage technology companies.","country":null,"category":null,"originalName":"博行资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:44:22.014Z","englishUpdatedAt":"2026-10-15T21:31:30.067Z","reviewedAt":"2026-10-15T21:31:30.067Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"a99b4438536406342208ab66b447db65bbbb6bbd9f06c3b8c7a7f5e3b49a0a70","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/boxing-capital"},{"id":"a6d5909a-f77e-428b-ab11-addb5447c2aa","kind":"institutions","code":"UB-I5926","name":"Haijinge Pharmaceutical","nameBasis":"transliterated","summary":"Haijinge Pharmaceutical, an investor using its parent company’s industry resources and corporate capital to invest in early-stage ventures.","description":"Haijinge Pharmaceutical, an investor using its parent company’s industry resources and corporate capital to invest in early-stage ventures.","country":null,"category":null,"originalName":"海金格医药","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:44:21.863Z","englishUpdatedAt":"2026-10-15T17:35:39.539Z","reviewedAt":"2026-10-15T17:35:39.539Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ec5fd16fcdc93838b75c80ab49d3a5001142c961c8225d64cb2a012d94726c7a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/haijinge-pharmaceutical"},{"id":"95afd5a1-bc98-472b-bb78-bf6660de6b29","kind":"institutions","code":"UB-I5913","name":"Nuohezhiyuan","nameBasis":"transliterated","summary":"Nuohezhiyuan, a Chinese corporate-backed industrial investor making strategic investments in startups.","description":"Nuohezhiyuan, a Chinese corporate-backed industrial investor making strategic investments in startups.","country":null,"category":null,"originalName":"诺禾致源","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:44:21.735Z","englishUpdatedAt":"2026-10-15T17:35:39.429Z","reviewedAt":"2026-10-15T17:35:39.429Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"65e541dc028ce137a86da357f46ca0504838ab9176c846223e6d333f09efebb7","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nuohezhiyuan"},{"id":"379cea5b-ef8c-4bca-a8e9-dac76fb4710d","kind":"companies","code":"UB-C3525","name":"Phil Rivers","nameBasis":"source-english","summary":"Provider of solutions for AI pharmaceutical research and development.","description":"Zheyuan Technology is an AI pharmaceutical research and development solutions provider","country":"China","category":null,"originalName":"哲源科技","eventDate":null,"website":"https://www.philrivers.com/","sourceUpdatedAt":"2026-10-03T00:00:00.000Z","englishUpdatedAt":"2026-10-15T20:38:52.104Z","reviewedAt":"2026-10-15T20:38:52.104Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"dbab255f1f6a665b5cce8060f9f4230e9924480f12948619228f25e905e4252a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/zheyuankeji"},{"id":"41094ea3-9968-479c-91be-cacf6e6694b5","kind":"institutions","code":"UB-I5933","name":"Taiya Capital","nameBasis":"transliterated","summary":"Taiya Capital, a Chinese venture capital firm focused on the growth of startup-stage enterprises.","description":"Taiya Capital, a Chinese venture capital firm focused on the growth of startup-stage enterprises.","country":null,"category":null,"originalName":"泰雅资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:44:21.925Z","englishUpdatedAt":"2026-10-15T21:21:01.639Z","reviewedAt":"2026-10-15T21:21:01.639Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fa982697936e36fde686880eb755c31b1121ef9c783be8db22da96bd01531643","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/taiya-capital"}],"path":"/news/3d5c8a2a-7746-46ea-adaf-535bc0ef27ae","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Phil Rivers","path":"/companies/zheyuankeji"}},"canonical":"https://uniquebase.ai/news/3d5c8a2a-7746-46ea-adaf-535bc0ef27ae"}